These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 12442468)
1. [Hepatitis B and C virus markers in hepatocellular carcinoma]. Tanikawa K Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):687-92. PubMed ID: 12442468 [No Abstract] [Full Text] [Related]
2. Hepatitis B virus infection--natural history and clinical consequences. Ganem D; Prince AM N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185 [No Abstract] [Full Text] [Related]
3. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study. Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185 [TBL] [Abstract][Full Text] [Related]
4. A cohort study to investigate hepatocellular carcinoma risk in hepatitis C patients. Wang CH; Mo LR; Chang KK; Lin RC; Kuo JJ Hepatogastroenterology; 2011; 58(107-108):904-8. PubMed ID: 21830414 [TBL] [Abstract][Full Text] [Related]
5. Occult hepatitis B virus infection and hepatocellular carcinoma development in patients with chronic hepatitis C. Raimondo G; Pollicino T; Levrero M; Craxì A Hepatology; 2011 Jul; 54(1):373-4; author reply 374. PubMed ID: 21520203 [No Abstract] [Full Text] [Related]
6. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946 [TBL] [Abstract][Full Text] [Related]
8. Viral pathogenesis of hepatocellular carcinoma in the United States. Liang TJ; Jeffers LJ; Reddy KR; De Medina M; Parker IT; Cheinquer H; Idrovo V; Rabassa A; Schiff ER Hepatology; 1993 Dec; 18(6):1326-33. PubMed ID: 8244256 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis B e antigen and the risk of hepatocellular carcinoma. Yang HI; Lu SN; Liaw YF; You SL; Sun CA; Wang LY; Hsiao CK; Chen PJ; Chen DS; Chen CJ; N Engl J Med; 2002 Jul; 347(3):168-74. PubMed ID: 12124405 [TBL] [Abstract][Full Text] [Related]
11. [Epidemiology of HBV related hepatocellular carcinoma in Japan]. Nishiguchi S; Tamori A; Kuroki T; Oka H; Tanaka T; Monna T Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):673-9. PubMed ID: 12442466 [No Abstract] [Full Text] [Related]
12. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260 [TBL] [Abstract][Full Text] [Related]
13. Development of hepatocellular carcinoma in chronic viral B and viral C liver diseases. Acalovschi M Rom J Gastroenterol; 2003 Jun; 12(2):123-30. PubMed ID: 12853999 [No Abstract] [Full Text] [Related]
14. Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease. Bréchot C; Nalpas B; Couroucé AM; Duhamel G; Callard P; Carnot F; Tiollais P; Berthelot P N Engl J Med; 1982 Jun; 306(23):1384-7. PubMed ID: 6281640 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B e Antigen--the dangerous endgame of hepatitis B. Liang TJ; Ghany M N Engl J Med; 2002 Jul; 347(3):208-10. PubMed ID: 12124411 [No Abstract] [Full Text] [Related]
16. Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma. Branda M; Wands JR Hepatology; 2006 May; 43(5):891-902. PubMed ID: 16628664 [No Abstract] [Full Text] [Related]
17. Common clinicopathological features of the patients with chronic hepatitis B virus infection who developed hepatocellular carcinoma after seroconversion to anti-HBs--a consideration of the pathogenesis of HBV-induced hepatocellular carcinoma and a strategy to inhibit it. Tsuboi Y; Ohkoshi S; Yano M; Suzuki K; Tsubata SS; Ishihara K; Ichida T; Sugitani S; Shibazaki K; Aoyagi Y Hepatogastroenterology; 2006; 53(67):110-4. PubMed ID: 16506387 [TBL] [Abstract][Full Text] [Related]
18. [Relationship between chronic viral hepatitis and hepatocellular carcinoma]. Karev VE; Tsinzerling VA; Komarova DV; Iakovlev AA Vopr Onkol; 2000; 46(4):427-32. PubMed ID: 11147418 [TBL] [Abstract][Full Text] [Related]
19. Impact of gender, viral transmission and aging in the prevalence of hepatitis B surface antigen. Tsay PK; Tai DI; Chen YM; Yu CP; Wan SY; Shen YJ; Lin DY Chang Gung Med J; 2009; 32(2):155-64. PubMed ID: 19403005 [TBL] [Abstract][Full Text] [Related]
20. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S; Nakashima Y; Kojiro M; Tabor E J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]